Clarapath

Clarapath

Pioneering a future of precision in pathology with automated solutions that promise superior quality, enhanced safety, and efficiency in lab operations.

Founded 2014

Hawthorne, United States 63 employees Series B Total: $75.16M Biotechnology, Health Care

Clarapath is a pioneering medical robotics company founded in 2014, with a vision to automate laboratory processes in pathology. The company's flagship product focuses on fully automating the microtomy station, aiming to enhance, standardize, and digitalize anatomic pathology. Located at the NY Genome Center, Clarapath's next-generation laboratory, extensive image repository, and analysis platform are equipped to manage the entire "tissue to bits" pipeline for specialized research projects and larger clinical needs. With a recent $16.00M Series B investment received on 17 November 2021 from Northwell Health, P5 Health Ventures, Epiphron Capital, The 4100 Group, and East Post Road Ventures, Clarapath is well-positioned to advance its mission of delivering superior quality, enhanced safety, and efficiency in lab operations. Through partnerships with both research and clinical clients, the company aims to offer higher-quality lab medicine, improved safety standards, and increased lab throughput while reducing laboratory costs and labor delays. As a biotechnology and healthcare industry player, Clarapath stands at the forefront of pioneering a future of precision in pathology with its automated solutions.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	$36.00M	4	Mayo Clinic, Northwell Health +2	24 Jul 2024
Series B	$16.00M	5	Northwell Health, P5 Health Ventures +3	17 Nov 2021
Series B	$16.00M	-		01 Apr 2021
Venture Round	$4.16M	-		27 Nov 2019
Venture Round	$3.00M	1	Northwell Health	01 Feb 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

$36.00M

Mayo Clinic, Northwell Health +2

24 Jul 2024

Series B

$16.00M

Northwell Health, P5 Health Ventures +3

17 Nov 2021

Series B

$16.00M

01 Apr 2021

Venture Round

$4.16M

27 Nov 2019

Venture Round

$3.00M

Northwell Health

01 Feb 2017

FAQ About Clarapath

Pioneering a future of precision in pathology with automated solutions that promise superior quality, enhanced safety, and efficiency in lab operations.

Clarapath was founded in 2014.

Clarapath is headquartered in Hawthorne, United States.

Clarapath operates in Biotechnology and Health Care. Its work centres on medical robotics, pathology automation, laboratory operations and anatomic pathology.

Clarapath has approximately 63 employees.

Clarapath has completed 5 funding rounds, raising a total of $75.16M. The latest funding stage is Series B.

Top alternatives and competitors to Clarapath include Aperio, BioImagene, Virasoft Corporation, Precision For Medicine, xMD Diagnostics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Clarapath and Aperio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Clarapath

Funding Rounds & Investors (5)

Clarapath Alternatives & Competitors

FAQ About Clarapath